EYLEA HD- aflibercept injection, solution

Regeneron Healthcare Solutions Inc.

EYLEA HD is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with:

• Neovascular (Wet) Age-Related Macular Degeneration (nAMD)
• Diabetic Macular Edema (DME)
• Diabetic Retinopathy (DR)

Refrigerate EYLEA at 2°C to 8°C (36°F to 46°F). Do not freeze. Do not use beyond the date stamped on the carton and container label. Store in the original carton until time of use to protect from light. Do not open sealed blister tray until time of use.